J. Schachter

发表

Oritavancin - a new semisynthetic lipoglycopeptide agent to tackle the challenge of resistant gram positive pathogens.

B. Das, C. Sarkar, J. Schachter, 2013, Pakistan journal of pharmaceutical sciences.